Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06694012 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

Study acronym: OCES-2
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary and study completion dates: May 31, 2050 to Mar 31, 2050
    • Start date changed from estimate of Nov 2024 to Nov 1, 2024
    • Study description expanded, about 1 word
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Osaka Metropolitan University
6 trials monitored
See all monitored trials
Diabetes
5,087 trials monitored
See 222 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
Type 2 Diabetes
2,231 trials monitored
See 111 trials at risk
and 2 more diseases
The aim of this study is to investigate the relationship between body fat distribution measured by CT scan and related risk factors with the risk of incident metabolic and cardiovascular disease in a prospective cohort study of Japanese men and women. The investigators will also investigate novel risk factors for metabolic and cardiovascular disease using molecular weight-based metallomics analysis.
Trial Details
NCT Number NCT06694012
Lead Sponsor Osaka Metropolitan University
Collaborators: The Ministry of Education, Culture, Sports, Science and Technology, Japan
Conditions
(from sponsor)		 Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, Diabetes Mellitus, Hypertension, Hyperglycemia, Hyperlipidemia, Dyslipidemia, Hyperuricemia or Gout +11 more
Related terms Atherosclerosis, Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, Fatty Liver, Gout, Hyperglycemia, Hyperlipidemias, Hypertension, Hyperuricemia, Insulin Resistance, Metabolic Syndrome, Obesity, Obesity, Abdominal, Renal Insufficiency, Chronic
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov